Does TRANDOLAPRIL\VERAPAMIL Cause C-reactive protein increased? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of C-reactive protein increased have been filed in association with TRANDOLAPRIL\VERAPAMIL. This represents 3.0% of all adverse event reports for TRANDOLAPRIL\VERAPAMIL.
8
Reports of C-reactive protein increased with TRANDOLAPRIL\VERAPAMIL
3.0%
of all TRANDOLAPRIL\VERAPAMIL reports
0
Deaths
1
Hospitalizations
How Dangerous Is C-reactive protein increased From TRANDOLAPRIL\VERAPAMIL?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANDOLAPRIL\VERAPAMIL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TRANDOLAPRIL\VERAPAMIL Cause?
Acute kidney injury (35)
Hypotension (35)
Cardiogenic shock (19)
Toxicity to various agents (19)
Bradycardia (18)
Condition aggravated (18)
Drug ineffective (15)
Dyspnoea (13)
Arterial disorder (12)
Dizziness (12)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which TRANDOLAPRIL\VERAPAMIL Alternatives Have Lower C-reactive protein increased Risk?
TRANDOLAPRIL\VERAPAMIL vs TRANEXAMIC ACID
TRANDOLAPRIL\VERAPAMIL vs TRANYLCYPROMINE
TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB
TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB-ANNS
TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB DERUXTECAN